Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Director | July 06, 2026 | July 08, 2026 |
| InspireMD, Inc.NSPR · Entity 7318 | Director · CEO and President | May 12, 2026 | May 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date July 06, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2036-07-06 | Direct | 20,000 |
Reported balance
After 2026-07-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-06 · Grant · Acquired 8,000 · Balance 20,000 F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.
InspireMD, Inc.
Report date May 12, 2026 · Filed May 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,556,658 |
Reported balance
After 2026-05-12 transaction · row 1
1 source rowRow 1 · 2026-05-12 · Purchase · Acquired 21,000 · Balance 3,556,658 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2026 Filed Jul 8, 2026 02:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001437749-26-022965 · rdgdoc.xml · derivative · entry 1 Slosman Marvin · CIK 0001796908 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common stock · 8,000 shares Expires 2036-07-06 F1 · derivative.exercise_date: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| May 12, 2026 Filed May 13, 2026 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 21,000 | $1.20 | $25,200.00 |
DisclosureSEC source: 0001493152-26-022775 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,556,658 Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 23:11 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantRestricted Stock Units | 1,114,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-002668 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,535,658 F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:51 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001437749-25-037467 · rdgdoc.xml · derivative · entry 1 Slosman Marvin · CIK 0001796908 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2035-12-08 F1 · derivative.exercise_date: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 10,330 | $2.42 | $24,998.60 |
DisclosureSEC source: 0001641172-25-021931 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,420,866 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $2.42. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 254,985 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001731 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 937,796 Underlying: Common Stock · 254,985 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantRestricted Stock Units | 558,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001731 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,410,536 F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 215,405 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001493152-24-003773 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 682,811 Underlying: Common Stock · 215,405 shares Expires 2034-01-23 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantRestricted Stock Units | 563,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-003773 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,852,119 F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:16 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 348,380 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001493152-23-018327 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,406 Underlying: Common Stock · 348,380 shares Expires 2033-05-17 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:16 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantRestricted Stock Units | 1,045,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-018327 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,288,620 F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| October 13, 2021 Filed Oct 14, 2021 21:01 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 48,855 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0001493152-21-025454 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,855 Underlying: Common Stock · 48,855 shares Expires 2031-10-13 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service. Read SEC document |
| October 13, 2021 Filed Oct 14, 2021 21:01 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantRestricted Stock Units | 146,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-025454 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,470 F1 · security: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of October 13, 2022, October 13, 2023 and October 13, 2024, subject to the Reporting Person's continued service. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 10:20 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOption to Purchase Common Stock · Derivative | 600,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001493152-21-009319 · ownership.xml · derivative · entry 3 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052,556 Underlying: Common Stock · 600,000 shares Expires 2031-04-19 F2 · derivative.exercise_date: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of April 19, 2022, April 19, 2023 and April 19, 2024, subject to the Reporting Person's continued service. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseWarrants · Derivative | 20,160 | $0.62 Strike: $0.68 | $12,499.20 |
DisclosureSEC source: 0001493152-21-003209 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,710 Underlying: Common stock · 20,160 shares Expires 2026-02-08 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit. F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 40,320 | $0.62 | $24,998.40 |
DisclosureSEC source: 0001493152-21-003209 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,453,538 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit. F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 40,320 shares of common stock and warrants to purchase 20,160 shares of common stock together, as part of 40,320 units, at a purchase price of $0.62 per unit. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:59 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions (right to buy) · Derivative | 391,762 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001493152-20-017128 · ownership.xml · derivative · entry 3 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,556 Underlying: Common stock · 391,762 shares Expires 2030-08-31 F4 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:59 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 1,175,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-017128 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,218 F1 · shares: These shares of common stock represent restricted stock units ("RSUs"), which each vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. F2 · balance_after: Consists of (i) an aggregate of 1,357,668 shares of common stock represented by RSUs, which vest over time, subject to the Reporting Person's continued service, and (ii) 55,550 shares of common stock. Read SEC document |
| August 31, 2020 Filed Feb 10, 2021 12:13 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions (right to buy) · Derivative | 391,762 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001493152-21-003209 · ownership.xml · derivative · entry 3 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,556 Underlying: Common stock · 391,762 shares Expires 2030-08-31 F2 · security: The Reporting Person has not engaged in any reportable transactions with respect to these derivative securities of the Issuer and is including his ownership of these securities for informational purposes only in this Form 4. F3 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 17:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseWarrants · Derivative | 55,550 | $0.45 Strike: $0.50 | $24,997.50 |
DisclosureSEC source: 0001493152-20-010852 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,550 Underlying: Common Stock · 55,550 shares Expires 2025-06-02 F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 55,550 shares of common stock and 55,000 warrants to purchase common stock together, as part of 55,000 units, at a purchase price of $0.45 per unit. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 17:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 55,550 | $0.45 | $24,997.50 |
DisclosureSEC source: 0001493152-20-010852 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,931 F1 · shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 55,550 shares of common stock and 55,000 warrants to purchase common stock together, as part of 55,000 units, at a purchase price of $0.45 per unit. F2 · balance_after: 182,381 of these shares of common stock represent restricted stock units ("RSUs"), which vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 18:17 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions (right to buy) · Derivative | 60,794 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001493152-20-000103 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,794 Underlying: Common Stock · 60,794 shares Expires 2030-01-02 F2 · derivative.exercise_date: The options vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the reporting person's continued service. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 18:17 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 182,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-000103 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,381 F1 · shares: These shares represent restricted stock units. This award vests in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the reporting person's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.